Spasticity scale test not enough to show Sativex benefits Published: 26 May 2020 A new study from Italy has found that Sativex, a type of medical cannabis licensed in the UK for some symptoms of multiple sclerosis MS, eases symptoms related to spasticity, even in those with no significant improvements